• Lifeist Wellness (LFST) portfolio business and wholly owned subsidiary CannMart Labs has produced its first products under the house brand “Roilty”
  • The company has received initial purchase orders from retail customers in Saskatchewan and anticipates additional sales to the Alberta provincial distributor
  • The company anticipates launching other Roilty-branded and higher margin cannabis 2.0 products in 2022
  • Lifeist Wellness Inc is a portfolio wellness company 
  • Lifeist Wellness Inc. (LFST) opened trading at C$0.105 per share

Lifeist Wellness (LFST) portfolio business and wholly-owned subsidiary CannMart Labs has produced its first products under the house brand “Roilty”.

The commercialization of proprietary house brands is a key part of CannMart’s strategy to introduce a larger portfolio of higher-margin cannabis 2.0 products to the Canadian market as part of Lifeist’s transition to profitable growth.

The company has received initial purchase orders from retail customers in Saskatchewan where the path to market is quickest due to the fewer regulatory complexities in the province. The remainder of this limited edition run of product SKUs is anticipated to be sold to the Alberta provincial distributor, as well as becoming available to purchase at CannMart.com.

Daniel Stern, CEO of CannMart Labs commented on the news.

“Our state-of-the-art BHO extraction facility is now live, manufacturing and shipping product, and negotiating numerous recreational sales agreements leveraging our sister company CannMart Inc.’s network of provincial customers.

Our first SKUs are exceptionally high-quality live resin products and show strong early interest from prospective customers. Now that we have reached this long-awaited milestone, we look forward to the next manufacturing run, broadening distribution to the larger provinces, and launching other Roilty-branded and higher-margin cannabis 2.0 products such as shatter and sugar wax in 2022. It’s also worth noting that an initial order for the Roilty-branded vape pen, Henry the Grape Ape, that was manufactured by a co-packer sold through CannMart Inc. into Alberta, sold out within seven days and additional quantities have been ordered to meet demand,” he added.

CannMart Labs operates a 6,000 square foot, state-of-the-art facility in Etobicoke, Ontario that is licensed by Health Canada for “standard processing.” The facility is capable of producing cannabis extracts, both in-house branded products and products processed for third parties. 

Lifeist is a portfolio wellness company leveraging advancements in science and technology. Portfolio business units include: CannMart.com and CannMart’s Canadian recreational cannabis distribution business facilitating recreational sales to a number of provincial government control boards.

Lifeist Wellness Inc. (LFST) opened trading at C$0.105 per share.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.